Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-19 4:05 pm Purchase |
2023-05-09 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Citadel Advisors LLC | 2,259,741 4.900% |
875,242 (+63.22%) |
Filing History |
| 2023-05-10 09:19 am Sale |
2023-04-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
STATE STREET CORP STT |
646,550 1.410% |
-2,660,686 (-80.45%) |
Filing History |
| 2023-02-14 1:10 pm Purchase |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Boxer Capital LLC | 3,163,795 6.900% |
325,559 (+11.47%) |
Filing History |
| 2023-02-14 10:07 am Purchase |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
RTW Investments, LP | 4,356,920 9.500% |
1,375,960 (+46.16%) |
Filing History |
| 2023-02-14 09:35 am Purchase |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
AVORO CAPITAL ADVISORS LLC | 3,060,000 6.700% |
1,595,000 (+108.87%) |
Filing History |
| 2023-02-14 08:26 am Sale |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Citadel Advisors LLC | 1,384,499 3.000% |
-1,025,343 (-42.55%) |
Filing History |
| 2023-02-10 1:00 pm Sale |
2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP |
INTERWEST PARTNERS X LP | 1,714,540 3.800% |
-1,535,004 (-47.24%) |
Filing History |
| 2023-02-10 11:26 am Sale |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
STATE STREET CORP STT |
3,307,236 7.240% |
-1,864,254 (-36.05%) |
Filing History |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
The Vanguard Group | 2,753,606 6.030% |
105,660 (+3.99%) |
Filing History |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
BLACKROCK INC BLK |
3,451,367 7.600% |
911,543 (+35.89%) |
Filing History |
| 2023-01-25 12:18 pm Sale |
2022-12-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
J P MORGAN CHASE & CO JPM |
4,004,767 8.700% |
-580,692 (-12.66%) |
Filing History |
| 2023-01-24 2:44 pm Sale |
2022-12-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Cowen Financial Products LLC | 1,500,326 3.280% |
-799,674 (-34.77%) |
Filing History |
| 2022-07-11 1:28 pm Purchase |
2022-06-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
STATE STREET CORP STT |
5,171,490 11.350% |
5,171,490 (New Position) |
Filing History |
| 2022-07-07 10:06 am Purchase |
2022-06-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
J P MORGAN CHASE & CO JPM |
4,585,459 10.000% |
1,419,009 (+44.81%) |
Filing History |
| 2022-06-17 4:02 pm Purchase |
2022-06-07 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Citadel Advisors LLC | 2,409,842 5.300% |
2,409,842 (New Position) |
Filing History |
| 2022-04-01 5:06 pm Unchanged |
2022-03-29 | 13D | PMV Pharmaceuticals, Inc. PMVP |
ORBIMED ADVISORS LLC | 6,589,330 14.500% |
0 (Unchanged) |
Filing History |
| 2022-02-14 5:01 pm Sale |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
VIKING GLOBAL INVESTORS LP | 1,790,284 3.900% |
-573,778 (-24.27%) |
Filing History |
| 2022-02-14 4:16 pm Purchase |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Boxer Capital LLC | 2,838,236 6.300% |
570,000 (+25.13%) |
Filing History |
| 2022-02-14 4:00 pm Sale |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Nextech V Oncology S.C.S. SICAV-SIF | 1,385,807 3.100% |
-1,142,483 (-45.19%) |
Filing History |
| 2022-02-14 08:39 am Purchase |
2021-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
RTW Investments, LP | 2,980,960 6.600% |
2,980,960 (New Position) |
Filing History |